Enhancer Zeste Homolog 2 (EZH2) expression is associated with a shorter time to the first systemic therapy in follicular lymphoma

被引：0

作者：

Szumera-Cieckiewicz, A. ^{[1
]}

Sokol, K. ^{[1
,2
]}

Rymkiewicz, G. ^{[2
]}

Paszkiewicz-Kozik, E. ^{[3
]}

Poleszczuk, J. ^{[4
]}

Borysiuk, A. ^{[2
]}

Kotarska, M. ^{[3
]}

Walewski, J. ^{[3
]}

Prochorec-Sobieszek, M. ^{[5
]}

机构：

[1] Inst Haematol & Transfus Med, Dept Diagnost Haematol, Warsaw, Poland

[2] Maria Sklodowska Curie Inst Oncol Ctr, Dept Pathol & Lab Med, Gliwice, Poland

[3] Maria Sklodowska Curie Inst Oncol Ctr, Dept Lymphoid Malignancies, Gliwice, Poland

[4] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland

[5] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol, Warsaw, Poland

来源：

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

OFP-13-004

引用

页码：S51 / S51

页数：1